PharmXchange the digital sales and marketing platform launched in the middle of 2022, has announced global pharma powerhouse Bayer ANZ as the latest major supplier to go live.
Greg Wallis, Sales Director of Bayer ANZ commented:
“At Bayer, we are constantly looking for opportunities to better deliver on our mission ‘Health for all, Hunger for none’ and this includes better serving more pharmacy customers whilst simplifying our operations. We are excited by Pharmxchange as it will help expand our reach and the quality of our engagement with Australian Pharmacies.”
Eric Moschietto, General Manager of PharmX Pty Ltd said
“Bayer ANZ is joining PharmXchange with its stable of 18 leading consumer health brands suchs as Berocca, Claratyne, Iberogast, Elevit, Canesten, Drixine among others. We are thrilled to be able to offer Australian Pharmacies the opportunity to purchase Bayer ANZ brands from their CSO wholesaler using PharmXchange our central and convenient platform.”
Ben Bynon, Head of Pharmacy and ecommerce of Bayer ANZ added:
“The whole of market approach proposed by PharmXchange is an exciting opportunity for Bayer to drive efficiencies for customers through the digitisation of the sales and ordering process. This directly supports our purpose in Consumer Health to empower the transformation of everyday health by ultimately improving access for consumers.”
Pharmacies wishing to register for PharmXchange can do so by contacting pharmacies@pharmxchange.com.au
